GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,708.50p
   
  • Change Today:
    -13.50p
  • 52 Week High: 1,722.50
  • 52 Week Low: 1,429.00
  • Currency: UK Pounds
  • Shares Issued: 4,917.86m
  • Volume: 4,340,832
  • Market Cap: 84,022m
  • RiskGrade: 74

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 4.7% 4.7%
Div Cover 1.3 1.4
Op Mrgn 9.3% 25.6%
ROCE 162.9%  
Latest F'cast
P/E 16.7 15.4
PEG 0.5 1.9
Pr/Revenue 3.0 2.8
Pr/Book 16.9  
Latest F'cast
Revenue 16.6% 8.1%
PBT -81.6% 298.1%
EPS 35.3% 8.3%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 26,431.00 6,600.00 111.40p 12.0 n/a -2% 74.00p 5.5%
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 30,150.63 7,718.66 110.87p 15.4 1.9 +8% 80.00p 4.7%
31-Dec-18 31,130.11 8,112.99 114.94p 14.9 4.1 +4% 80.18p 4.8%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 21-Jun-2017 14:35 RNS
GSK presents Shingrix PhIII study results at ACIP 21-Jun-2017 14:05 RNS
GSK confirms start date for Luke Miels 19-Jun-2017 16:29 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
20-Jun-17 Sell Victoria Whyte 1,693.00p 4,820 81,602.60
20-Jun-17 Exercise of option Victoria Whyte 1,147.00p 4,820 55,285.40
09-Jun-17 Transfer From Simon Dingemans 0.000p 7 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,708.50p
Change Today -13.50p
% Change -0.78 %
52 Week High 1,722.50
52 Week Low 1,429.00
Volume 4,340,832
Shares Issued 4,917.86m
Market Cap 84,022m
RiskGrade 74

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.06% below the market average53.06% below the market average53.06% below the market average53.06% below the market average53.06% below the market average
31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average
Price Trend
43.13% above the market average43.13% above the market average43.13% above the market average43.13% above the market average43.13% above the market average
44.26% above the sector average44.26% above the sector average44.26% above the sector average44.26% above the sector average44.26% above the sector average
Income
60.23% above the market average60.23% above the market average60.23% above the market average60.23% above the market average60.23% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
8.35% above the market average8.35% above the market average8.35% above the market average8.35% above the market average8.35% above the market average
18.18% below the sector average18.18% below the sector average18.18% below the sector average18.18% below the sector average18.18% below the sector average

What The Brokers Say

Strong Buy 15
Buy 0
Neutral 11
Sell 0
Strong Sell 3
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  1st Interim Q4
Ex-Div 11-May-17 23-Feb-17
Paid 13-Jul-17 13-Apr-17
Amount 19.00p 23.00p

Trades for 23-Jun-2017

Time Volume / Share Price
17:05 13,200 @ 1,714.16p
17:04 50,000 @ 1,710.71p
17:03 4,277 @ 1,711.66p
17:03 70,966 @ 1,710.62p
17:02 505 @ 1,714.07p

GlaxoSmithKline Key Personnel

Chair Moncef Slaoui
CFO Simon Dingemans
CEO Emma Walmsley

Top of Page